Thomson Reuters Foundation

Inform - Connect - Empower

Qualitest recalls birth control pills - FDA

Source: Thomson Reuters Foundation - Fri, 16 Sep 2011 22:19 GMT
Author: Reuters
Tweet Recommend Google + LinkedIn Email Print
Leave us a comment

(Corrects link to affected lot numbers)

WASHINGTON, Sept 16 (Reuters) - Qualitest Pharmaceuticals is voluntarily recalling several lots of birth control pills because of a packaging error that could leave women at risk for unplanned pregnancy, the U.S. Food and Drug Administration (FDA) said.

Select blisters were rotated 180 degrees within the card, reversing the weekly tablet orientation and making the lot number and expiration date no longer visible, the FDA said in a statement on its website.

The error means the daily regimen for the oral contraceptives may be incorrect and could leave women at risk of an unplanned pregnancy, it said. The defects do not pose any immediate health risks.

"This packaging error and the potential for this error to have affected other oral contraceptive products resulted in the company issuing the recall of multiple lots," the agency said.

The recall takes effect immediately. It includes Cyclafem 7/7/7, Cyclafem 1/35, Emoquette, Gildess FE 1.5/30, Gildess FE 1/20, Orsythia, Previfem and Tri-Previfem.

The affected lot numbers can be found at

Qualitest is a unit of Endo Pharmaceuticals Holdings Inc. (Reporting by Ian Simpson; editing by Cynthia Johnston and Andre Grenon)

We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of the Thomson Reuters Foundation. For more information see our Acceptable Use Policy.

comments powered by Disqus